Notice of Allowance of Zyleris U.S. Patent Application
April 10, 2019. Lake Bluff, IL. Zyleris Pharmatech, a leading topical formulation development service provider, received a notice of allowance of U.S. patent application titled “Topical Compositions for Improved Delivery of Active Agents”. This technology is about improvement of delivery of active agents from ointment formulations, particularly petrolatum-based formulations. Ointments offer many benefits in topical…
2018 ContractPharma Annual Contracting and Outsourcing Conference and Tabletop Exhibition
Zyleris will exhibit at 2018 ContractPharma Annual Conference and Tabletop Exhibition September 27-28 at the Hyatt Regency in New Brunswick, NJ. Our booth number is 136.
2017 AAPS Meeting
Zyleris exhibited at the 2017 AAPS Meeting on November 13-15 at the San Diego Convention Center. Our booth is #2438.
2017 ContractPharma 16th Annual Contracting and Outsourcing Conference and Tabletop Exhibition
Zyleris exhibited at 2017 ContractPharma 16th Annual Contracting and Outsourcing Conference and Tabletop Exhibition on September 14-15 at the Hyatt Regency in New Brunswick, NJ. Our table is #64.
High-Throughput Screening of Compound Library for Topical and Transdermal Delivery
Chicago, IL, U.S.A, April 27, 2011 – Zyleris PharmaTech (www.Zyleris.com) has announced the launch of a new drug development service: high-throughput screening of compound library to identify drug candidates for topical and transdermal delivery. The screening service utilizes Zyleris’ Franz Cell-based high-throughput technology. Each screening system consists of a compact 108-cell screening station with flexibility for…
High-Throughput Formulation Screening Service for Topical and Transdermal Drug Development
Chicago, IL, U.S.A, July 26, 2010 – Zyleris PharmaTech (www.Zyleris.com) has announced today the launch of its high-throughput formulation screening service for topical and transdermal drug development based on the company’s innovative experimentation technology. Zyleris’ technology is designed to transform topical and transdermal drug development. The technology utilizes Franz Cell principle in a high-throughput fashion,…